| Name | BAY-784 |
|---|---|
| Synonyms |
BAY1214784
Spiro[3H-indole-3,4'-[4H]thiopyran]-5-cboxamide, N-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]methyl]-2-cyclopropyl-1-[(4-fluorophenyl)sulfonyl]-1,2,2',3',5',6'-hexahydro-, 1',1'-dioxide, (2S) BAY784,BAY (S)-N-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)methyl)-2-cyclopropyl-1-((4-fluorophenyl)sulfonyl) |
| Description | BAY-784 is a gonadotropin releasing hormone receptor (GnRH-R) antagonist probe with IC50s of 21 and 24 nM for human and rat GnRH-R, respectively[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 21 nM (human GnRH-R), 24 nM (rat GnRH-R)[1] |
| In Vivo | BAY-784 (0.5, 3, 10, and 30 mg/kg; 24 hours; single p.o.) suppresses the plasma luteinizing hormone (LH) concentration in ovariectomized (OVX) rats in a dose-dependent manner[1]. Animal Model: OVX rats[1] Dosage: 0.5, 3, 10, and 30 mg/kg (Pharmacokinetic Analysis) Administration: Single p.o. Result: ED50=4.5 mg/kg (4/8 h). The t1/2=13-17 h, 18 h, and 7 h for male Wistar rat, female beagle, and female cynomolgus, respectively. |
| References |
| Molecular Formula | C29H26ClF4N3O5S2 |
|---|---|
| Molecular Weight | 672.11 |